文献速递妇科

在德克萨斯州无家可归者中实施人乳头瘤病毒自采样及随访障碍:EMPOWER研究

Implementation of Human Papillomavirus Self-Collection and Barriers to Follow-Up Among Unhoused Individuals in Texas: The EMPOWER Study.
PubMed 文献 · Obstet Gynecol · 2025-07-17

该单臂可行性试验于2024年5月至10月在德克萨斯州奥斯汀社区资源中心前瞻性纳入89名25岁及以上无家可归者,提供高危人乳头瘤病毒(HPV)自采样。87人采集样本,83份有效样本中21份(25.3%)高危HPV阳性,仅46人(52.9%)收到结果,21名阳性者中4人(19.0%)接受阴道镜检查。结果表明自采样可行,但阳性者随访存在显著障碍,需未来研究减少失访。

要点

  • 无家可归者高危HPV自采样可行,87人采集样本,83份有效。
  • 有效样本中21份(25.3%)高危HPV阳性,62份(74.7%)阴性。
  • 仅46/87(52.9%)收到结果,21名阳性者中4人(19.0%)接受阴道镜检查。

核心结论

  • 结果表明在无家可归者中实施高危HPV自采样是可行的,但阳性者随访存在显著障碍。
  • 高危HPV自采样可能提高筛查不足人群的宫颈癌筛查率,但癌前病变的随访诊断和治疗对预防宫颈癌是必要的。
  • 未来研究需要确定降低失访率的策略。

研究设计与样本

  • 单臂可行性试验,于2024年5月至10月在德克萨斯州奥斯汀社区资源中心前瞻性纳入89名25岁及以上无家可归者。
  • 提供宫颈癌简短教育和高危HPV自采样机会,样本送至商业实验室检测,结果当面或电话通知。
  • 高危HPV阳性者导航至阴道镜随访,所有参与者完成退出调查。

主要发现

  • 89名参与者中87人采集样本,6份样本无效(6.9%),其中2份重新采集。
  • 83份有效样本中21份(25.3%)高危HPV阳性,62份(74.7%)高危HPV阴性。
  • 87名采集样本者中仅46人(52.9%)收到结果,尽管多次尝试联系。
  • 21名高危HPV阳性者中4人(19.0%)已接受阴道镜检查。
  • 随访护理存在诸多障碍。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although cervical cancer rates are low in the United States, certain populations experience disproportionate incidence and mortality attributable to inadequate access to screening, diagnosis, or treatment. High-risk human papillomavirus (HPV) self-collection is an effective strategy to increase uptake of cervical cancer screening; however, its effectiveness among unhoused individuals is unknown. The objective of this study was to assess the feasibility of HPV self-collection among unhoused individuals and to identify barriers to follow-up diagnosis and treatment. METHODS: This is a single-arm feasibility trial. Unhoused individuals aged 25 years or older were prospectively enrolled in Austin, Texas, at community resource centers. They were offered brief education about cervical cancer and the opportunity to screen with high-risk HPV self-collection. Samples were sent to a commercial laboratory for testing. Result notification occurred in person or by telephone. Participants with high-risk HPV-positive results were navigated to follow-up with colposcopy. All participants answered an exit survey. RESULTS: From May to October 2024, 89 participants were enrolled, of whom 87 collected samples. There were six invalid samples (6.9%), two of which were recollected. Of the 83 valid samples, 21 (25.3%) were positive for high-risk HPV and 62 (74.7%) were negative for high-risk HPV. Only 46 of 87 participants who collected samples (52.9%) received their results despite multiple attempts to contact them. Of the 21 participants with high-risk HPV-positive results, four (19.0%) have undergone colposcopy. There were numerous barriers to follow-up care. CONCLUSION: Our results suggest that it is feasible to implement high-risk HPV self-collection among unhoused individuals; however, there are significant barriers to follow-up for those who test positive. Although high-risk HPV self-collection may improve cervical cancer screening rates among underscreened populations, follow-up diagnosis and treatment of precancerous lesions are necessary to prevent cervical cancer. Future research is needed to identify strategies to decrease loss to follow-up rates. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT06109870.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Fallah PN, Bowman P, Tran C, et al. Implementation of Human Papillomavirus Self-Collection and Barriers to Follow-Up Among Unhoused Individuals in Texas: The EMPOWER Study. Obstet Gynecol. 2025. PMID: 40674748. doi:10.1097/AOG.0000000000006003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。